2012 Annual General Meeting

On May 4, 2013, Jiangsu Nannong High-tech Co., Ltd. held the 2012 annual general meeting of shareholders, the Board of supervisors and the first meeting of the fourth board of directors. A total of 11 shareholders and authorized representatives attended the meeting, representing 100% of the shares. The company's supervisors and senior managers attended the meeting as non-voting delegates.

The meeting reviewed and passed the motions of the company's board of directors, the company's Board of supervisors, and the "Amendments to the articles of Association of Jiangsu Nannong High-tech Co., LTD.";

General manager He Hairong said that the dynamic acceptance of the vaccine production line is of great significance for the development of Nannong High-tech Co., LTD. We seriously rectify the problems of the expert group inspection, and implement GMP more strictly and standardized in the future work to improve management efficiency.

The meeting passed the motions of "The Company's 2012 annual Business Work Report", "the Company's 2012 annual Financial Report", "the Company's 2013 annual business plan" and "on the investment of animal house construction project".

In 2013, the company will fully promote the implementation of the development strategy plan, around the theme of "new technology, heart service, new benchmark", adhere to technology leadership, concentration, innovation, first-class veterinary drugs, first-class brands, first-class enterprises, and strive to complete the 2013 business objectives formulated by the board of directors.